Shanghai found its first Covid-19 cases in a week as outbreaks continue to flare around the country, while the resort island of Hainan fell short in its effort to stop transmission by Friday (Aug 12) ... ( read original story ...)
Hongene Biotech Seeks Pre-IPO Funds at $6 Billion Value
Hongene Biotech Corp. is weighing a new funding round that could value the Chinese synthesis blocks and enzymes maker at about $6 billion, people familiar with the matter said. ( read original story ...)
China Tourism Group Duty Free gets approval for IPO, targets biggest Hong Kong listing this year at US$2.7 billion
The company's flotation has received approval from the Hong Kong stock exchange's listing committee The company's mainland shares have dropped this week as Covid-19 restrictions hit the duty-free ... ( read original story ...)
Consolidation Expected For China Stock Market
The China stock market has climbed higher in four straight sessions, gathering almost 85 points or 2.6 percent along the way. The Shanghai Composite Index now rests just above the 3,245-point plateau ... ( read original story ...)
After overcoming a tough Q2, Shanghai gears up for economic recovery in H2
VCG. Shanghai officials on Monday highlighted the city's remarkable achievements over the past decade and vowed further efforts in building the city ... ( read original story ...)
YanGuFang International Begins U.S. IPO Effort
YanGuFang International has filed to raise $23 million in a U.S. IPO. YGF is subject to ongoing risks in China. Read more about the IPO here. ( read original story ...)
Chart of the Day: China’s IPO Queue Gets Longer as Covid Curbs Ease
The number of companies waiting in line to go public on the Chinese mainland’s stock markets has reached around 1,000, as the economy began to pick up steam after Covid restrictions in some of its ... ( read original story ...)